September 2020
CIPA Journal
By Courtney A. Bolin; Timothy P. McAnulty
In the US, the introduction of the inter-partes review (IPR) – permitting a third party to challenge the validity of a granted US patent before the USPTO – has been welcomed. It provides a mechanism for challenging patents in a less costly and potentially more rapid forum than through the US courts. However, it adds another possibility, together with ITC proceedings (and post-grant review) to the landscape of US patent litigation and for adding complexity and potential cost in the US.
In their update on how increasingly the USPTO is denying “institution” of such proceedings (i.e., refusing to permit such proceedings to progress), Courtney Bolin and Tim McAnulty describe the key factors, identified in the recent decision in Apple v Fintiv, for denying institution of an IPR where there are parallel proceedings. These include the efficient use of judicial resources – a factor which is of wider interest, in other jurisdictions, and the discussion illustrates situations that may be relevant to the use of judicial resources. They also note some tactical considerations where such a challenge is being contemplated or proceedings under a US patent have been threatened. And as an interesting additional snippet are some figures on time to trial in different US jurisdictions, showing that not only can a party spend a considerable amount of money in such proceedings, but can do so on a relatively short timetable.
Read "US Update: Levelling the Playing Field on Challenging Patents?"
United States Patent and Trademark Office (USPTO), Patent Trial and Appeal Board (PTAB), Apple, Inc.
Originally printed in CIPA Journal on September 2020. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.